Fundz

Pfizer To Acquire Reviral And Its Respiratory Syncytial Virus Therapeutic Candidates

PUBLIC · PFEApr 07, 2022

Acquiring Company

Pfizer

Acquired Company

Virus Candidates

New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticals

Description

Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV).

Quick answer

Pfizer is acquiring Virus Candidates, announced April 7, 2022. Pfizer is based in New York, New York, United States.

How much did Pfizer pay for Virus Candidates?
The deal value was not disclosed.
Where are Pfizer and Virus Candidates based?
Pfizer is based in New York, New York, United States.
Who are the decision-makers at Pfizer?
Fundz holds 2 contacts at Pfizer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Therapeutics and Pharmaceutical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Pfizer, and when

When Pfizer changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pfizer, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pfizer

Location

66 Hudson Blvd E

New York, New York, United States

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pfizer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Elif
Likely contact at this company
••••••••@••••••••

See Elif's verified email →

Albert
Senior decision-maker at this company
••••••••@••••••••

See Albert's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Pfizer's next move

Learn about Strategic plan

Frequently asked

Who acquired Virus Candidates?

Virus Candidates was acquired by Pfizer, based in New York. The deal was reported on April 7, 2022. Pfizer is publicly traded (PFE) and operates in Biotechnology.

When did Pfizer acquire Virus Candidates?

Pfizer's acquisition of Virus Candidates was reported on April 7, 2022. Pfizer Inc. (NYSE: PFE) and ReViral Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Virus Candidates do?

Virus Candidates is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.